Ramipril
ApprovedCompleted 0 watching 0 views this week🔥 Hot
84
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Hypertension
Conditions
Hypertension
Trial Timeline
Mar 1, 2007 → Dec 1, 2008
NCT ID
NCT00473174About Ramipril
Ramipril is a approved stage product being developed by Pfizer for Hypertension. The current trial status is completed. This product is registered under clinical trial identifier NCT00473174. Target conditions include Hypertension.
Hype Score Breakdown
Clinical
30
Activity
20
Company
9
Novelty
10
Community
12
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00473174 | Approved | Completed |
| NCT00044265 | Approved | Completed |
Competing Products
20 competing products in Hypertension